Tower Research Capital (TRC)’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,049
Closed -$9.27K 6274
2023
Q4
$9.27K Sell
3,049
-3,868
-56% -$11.8K ﹤0.01% 4412
2023
Q3
$19.6K Buy
6,917
+5,211
+305% +$14.8K ﹤0.01% 3393
2023
Q2
$4.44K Buy
+1,706
New +$4.44K ﹤0.01% 4923
2022
Q4
Sell
-5,859
Closed -$11K 6569
2022
Q3
$11K Sell
5,859
-141
-2% -$265 ﹤0.01% 4486
2022
Q2
$18K Buy
6,000
+1,442
+32% +$4.33K ﹤0.01% 3928
2022
Q1
$17K Buy
4,558
+2,380
+109% +$8.88K ﹤0.01% 3724
2021
Q4
$25K Buy
2,178
+1,781
+449% +$20.4K ﹤0.01% 3449
2021
Q3
$7K Buy
+397
New +$7K ﹤0.01% 4698